TITLE

Daily Variations in Sputum Volume in Chronic Bronchitis

AUTHOR(S)
Ashcroft, Thomas
PUB. DATE
January 1965
SOURCE
British Medical Journal;1/30/1965, Vol. 1 Issue 5430, p288
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64057407

 

Related Articles

  • Clinical study to evaluate the efficacy of a compound Unani herbal formulation Sharbate-Unsul Murakkab in Sual-e-Muzmin (chronic bronchitis). Zaidi, S. A. R.; Ahmad, M. A.; Aslam, K. M.; Rauf, A.; Mukherjee, A. K. // Australian Journal of Medical Herbalism;2010, Vol. 22 Issue 3, p89 

    The present clinical study was undertaken as a single blind placebo controlled study to determine the efficacy of the test drug in the treatment of chronic bronchitis as there is no curative treatment available for chronic bronchitis in modern medicine. Unani compound formulation i.e....

  • bronchoblennorrhea.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p321 

    A definition of the term "bronchoblennorrhea," which refers to chronic bronchitis in which sputum is copious and thin, is presented.

  • Physiotherapy and intermittent positive-pressure ventilation of chronic bronchitis. Newton, D.A.G.; Bevans, H.G. // British Medical Journal;12/2/1978, Vol. 2 Issue 6151, p1525 

    Examines the usefulness of physiotherapy and intermittent positive-pressure ventilation (IPPV) for the treatment of chronic bronchitis in Great Britain. Effects of breathing exercises on blood gas tensions; Changes in patients receiving physiotherapy and IPPV; Implications of the decrease in...

  • Chronic bronchitis: is bacteriological examination of sputum necessary? Peterson, I.C.; Petrie, G.R.; Crompton, G.K. // British Medical Journal;8/19/1978, Vol. 2 Issue 6136, p537 

    Assesses the necessity of routine bacteriological examination of purulent sputum for the management of infective exacerbations of chronic bronchitis. Performance of chemotherapy to patients; Conversion of sputum from purulent to mucoid; Valuability of specimen examination.

  • Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Stockley, R. A.; Bayley, D.; Hill, S. L.; Hill, A. T.; Crooks, S.; Campbell, B. J.; Campbell, E J // Thorax;May2001, Vol. 56 Issue 5, p366 

    Background: Airway inflammation, with recruitment of neutrophils to the airway lumen, results in purulent secretions and a variety of potential adverse consequences for patients with chronic bronchitis and bronchiectasis. We hypothesised that gradations of sputum colour would...

  • bronchitis. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p129 

    An encyclopedia entry for "bronchitis" is presented. It refers to a bronchial disease in which air passages to the lungs are inflamed. This condition results in a cough that may release considerable amount of sputum or phlegm and may be characterized as acute or chronic. Both acute bronchitis...

  • mecysteine hydrochloride.  // Royal Society of Medicine: Medicines;2002, p348 

    This article presents information on mecysteine hydrochloride or methyl cysteine hydrochloride, a drug used to reduce the viscosity of sputum and so acts as an expectorants in patients with disorders of the upper respiratory tract (eg chronic asthma or bronchitis). Administration is oral.

  • Diagnosis and treatment of chronic cough in China: an insight into the status quo. Kefang Lai; Wei Luo; Guangqiao Zeng; Nanshan Zhong // Cough (17459974);2012, Vol. 8 Issue 1, p4 

    Chronic cough is a very common complaint in clinics throughout China. Clinical and basic science research on chronic cough started late, but in recent years the effort has yielded promising findings regarding the etiological diagnosis, treatment and pathogenesis. We found that inflammation in...

  • Chronic obstructive pulmonary disease: clinical signs and infections. Banning, Maggi // British Journal of Nursing;9/14/2006, Vol. 15 Issue 16, p874 

    Chronic obstructive pulmonary disease (COPD) is a pathological condition that involves excessive production of mucus, chronic cough and inflammatory changes leading to airway limitation. The most common cause of COPD is cigarette smoking. COPD can be categorized into either chronic bronchitis or...

  • mucolytic (Major drug group).  // Royal Society of Medicine: Medicines;2002, p378 

    The article presents information on the respiratory agents called mucolytic. The drugs dissolve or break down mucus. They are used to reduce the viscosity of sputum in the upper airways and facilitate expectoration. They can be used to treat asthma and chronic bronchitis. They can also be used...

Share

Read the Article

Other Topics